| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/19/2005 | CN1568190A Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
| 01/19/2005 | CN1566358A Enzymolysis product of animal brain and its preparation method and pharmaceutical use |
| 01/19/2005 | CN1566356A Method for preparing earthworm bioactive peptide and earthworm biological micro-fertilizer and use thereof |
| 01/19/2005 | CN1566343A Method for making chitosan nanoparticle-pcDNA3.1-hVEGF gene complex |
| 01/19/2005 | CN1566158A Recombinant vaccine for prevention and treatment of SARS virus |
| 01/19/2005 | CN1566157A Preparing method and use for osteoprotegerin fusion protein |
| 01/19/2005 | CN1566156A Recombinant target fusion protein GnRH-TNFam and its antitumor use |
| 01/19/2005 | CN1566154A Novel hepatocyte growth factor, preparing process and application thereof |
| 01/19/2005 | CN1566151A Sugar latticeing material CHB extracted from serum of turtle or/and tortoise, preparation process and application in pharmacy thereof |
| 01/19/2005 | CN1566149A Immunosuppressive receptor derived from dendritic cell, coded sequence and uses thereof |
| 01/19/2005 | CN1566148A Tumor suppressor, coded protein and application thereof |
| 01/19/2005 | CN1566144A Functional protein in SARS coronavirus |
| 01/19/2005 | CN1566143A Antigenic determinant of SARS coronavirus nucleocapsid protein and application thereof |
| 01/19/2005 | CN1566142A Polypeptide drug for inhibiting SARS coronavirus from infecting host cell |
| 01/19/2005 | CN1566134A Non-structural protein gene of coronavirus and use thereof |
| 01/19/2005 | CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 01/19/2005 | CN1565626A Nutrient agent |
| 01/19/2005 | CN1565625A Preparing process of insulin powder inhalant |
| 01/19/2005 | CN1565624A Carbowaxing recombiant human growth hormone medicine and its preparation process |
| 01/19/2005 | CN1565623A Calcitonin composition |
| 01/19/2005 | CN1565622A Therapeutic agent to recover hematopoiesis function and its compositions and usage |
| 01/19/2005 | CN1565621A Obtainment of cell growth inhibiting polypeptide and its usage |
| 01/19/2005 | CN1565620A Usage of IL-1 acceptor antagon in the treatment of SARS |
| 01/19/2005 | CN1565619A Novel usage of soluble P-lectin and anthrax lethal toxin |
| 01/19/2005 | CN1565415A Biological preparation enriched with activation regeneration factor and its uses |
| 01/19/2005 | CN1185348C Chimeric interleukin-6 soluble receptor/ligand protein and application thereof |
| 01/19/2005 | CN1185344C Protein for blocking platelet adhesion |
| 01/19/2005 | CN1185343C New growth-differentiation factor of the TGF-beta family |
| 01/19/2005 | CN1185341C Method for preparing medicine using silkworm expressed human beta interferon |
| 01/19/2005 | CN1185340C Method for producing medicine using silkworm expressed human alpha2b interferon |
| 01/19/2005 | CN1185261C Interleukin -2/granulocyte-macrophage colony stimulating factor fusion protein |
| 01/19/2005 | CN1185258C Trivalent chromium composition and its use |
| 01/19/2005 | CN1185257C Glucagon insulinotropic complexes, compositions and methods |
| 01/19/2005 | CN1185253C Neoglycoproteins |
| 01/19/2005 | CN1185252C Somatostatin peptides |
| 01/19/2005 | CN1185251C Novel LHRH-antagonists with improved solubility characteristics |
| 01/19/2005 | CN1185250C Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/19/2005 | CN1185021C Partial chitosan bio-canula capable of inducing and promoting effective regeneration of nerve and its preparation method |
| 01/19/2005 | CN1185010C Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins |
| 01/19/2005 | CN1185009C Eye preparation |
| 01/19/2005 | CN1185008C Therapeutic compositions containing glutathione analogs |
| 01/19/2005 | CN1184958C Erythropoietin Liposomal dispersion |
| 01/18/2005 | US6844459 Pharmaceutical Composition |
| 01/18/2005 | US6844424 Using birds bone derivatives to replace cattle sources of cartilage in nutrients, veterinary medicine and cosmetics; prevention of prion and/or viral diseases |
| 01/18/2005 | US6844423 Polypeptide for use in the diagnosis, prevention and treatment infections |
| 01/18/2005 | US6844422 Inhibitor protein of the wnt signal pathway |
| 01/18/2005 | US6844421 Inhibit undesired human CD4+ T cell immune responses and can be used to treat disease such as multiple sclerosis and to prevent graft rejection and graft versus host disease |
| 01/18/2005 | US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 01/18/2005 | US6844327 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 01/18/2005 | US6844325 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 01/18/2005 | US6844323 Polypeptide-calcitonin 11 and the polynucleotide encoding it |
| 01/18/2005 | US6844322 Administering a milk-secretion stimulating amount of: i)an estrogen-like agent; ii) a progestational agent; and iii) a somatotropin; may include adjusting the photo-period to which the animal is exposed |
| 01/18/2005 | US6844321 Preparing an aqueous solution comprising glucagon-like peptide-1 (GLP-1), analogue, a salt, and an organic solvent, isolation of the crystals after formation |
| 01/18/2005 | US6844319 Targeting Hepatic Stellate Cells (HSC) involved in sclerotic and/or fibrotic diseases with carrier linked to amino acid sequence SRNLIDC |
| 01/18/2005 | US6844318 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 01/18/2005 | US6844317 Methods for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 01/18/2005 | US6844315 Determining peptide's therapeutic effect by administering to subject prone to showing signs of diabetes; determining development of diabetes |
| 01/18/2005 | US6844314 Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 01/18/2005 | US6844312 Production of tyrosine hydroxylase positive neurons |
| 01/18/2005 | US6844193 Detecting ligand for fibroblast growth factor binding protein; obtain nucleotide sequence libraries, obtain cells, transform cell with nucleotide sequences, monitor kinase activity, amplified activity indicates presence of ligand |
| 01/18/2005 | US6844191 Osteogenic cell growth using a TGFβ1-von Willebrand's factor fusion protein |
| 01/18/2005 | US6844190 Binding protein for use in the treatment of pain, schizophrenia, depression, obsessive compulsive disorder, anxiety, migraines and pain |
| 01/18/2005 | US6844189 Chromosome 17P-linked prostate cancer susceptibility gene |
| 01/18/2005 | US6844181 Method of inhibiting fungal growth |
| 01/18/2005 | US6844179 Protein and DNA thereof |
| 01/18/2005 | US6844178 Recombinant kid pregastric esterase and methods for its production and use |
| 01/18/2005 | US6844175 Methods of inhibition using glycosyl sulfotransferase-3 |
| 01/18/2005 | US6844168 Compositions comprising polynucleotides encoding human fibroblast growth factor receptor and uses thereof |
| 01/18/2005 | US6844161 Modular protein libraries and methods of preparation |
| 01/18/2005 | US6844153 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 01/18/2005 | US6844011 Methods for inhibiting rejection of transplanted tissue |
| 01/18/2005 | US6844010 Forming burst free, sustained, programmable release micro-capsules; dissolving active material and blend of glycolide-lactide polymers in methylene chloride; converting to water-oil-water emulsion; removing solvent and lyophilizing |
| 01/18/2005 | US6843994 To suppress the mutagenesis substances; health |
| 01/18/2005 | US6843992 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 01/18/2005 | US6843991 Use of the M3 protein of MHV68 to block binding of a chemokine to its receptor |
| 01/18/2005 | US6843989 Administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand |
| 01/18/2005 | US6843988 Synferon |
| 01/18/2005 | US6843980 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 01/18/2005 | CA2367127C Macrocyclic peptides active against the hepatitis c virus |
| 01/18/2005 | CA2269638C Ice inhibiting peptides |
| 01/18/2005 | CA2144043C Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/18/2005 | CA2064993C Non-porous collagen sheet for therapeutic use, and the method and apparatus for preparing it |
| 01/15/2005 | CA2435136A1 Reducing polyglutamine-based aggregation |
| 01/13/2005 | WO2005003782A1 Secreted polypeptide species reduced in cardiovascular disorders |
| 01/13/2005 | WO2005003353A1 Genetically modified brucella cells and pharmaceutical composition containing these cells |
| 01/13/2005 | WO2005003351A1 Differential expression of nucleic acid molecules |
| 01/13/2005 | WO2005003350A2 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER’S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/13/2005 | WO2005003347A2 Dna-based aptamers for human cathepsin g |
| 01/13/2005 | WO2005003336A2 Newly identified cholinephosphotransferases and ethanolaminephosphotransferases |
| 01/13/2005 | WO2005003300A2 Tissue scaffold having aligned fibrils, apparatus and method for producing same, and methods of using same |
| 01/13/2005 | WO2005003296A2 Albumin fusion proteins |
| 01/13/2005 | WO2005003293A2 pRNA CHIMERA |
| 01/13/2005 | WO2005003292A2 Composition and method for self-assembly and mineralization of peptide amphiphiles |
| 01/13/2005 | WO2005003289A2 Ap1 amine oxidase variants |
| 01/13/2005 | WO2005003288A2 Diagnostic methods , prognostic methods and pharmaceutical compositions for neurodegenerative diseases like alzheimer’s disease by modulating and investigating genes rgs4 and itpkb, their gene products or fragments and derivatives thereof |
| 01/13/2005 | WO2005003177A2 Molecules for the targeting and the in situ assembly of therapeutic proteins and use thereof |
| 01/13/2005 | WO2005003167A1 Ubiquitinated tnf receptor 2 and its uses |
| 01/13/2005 | WO2005003166A1 Fluorescein-labelled peptides |
| 01/13/2005 | WO2005003164A2 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases |
| 01/13/2005 | WO2005003163A1 Sushi peptide multimer |